VERO - Venus Concept Inc Debt to Book Capitalization Ratio

Corporate company logo of Venus Concept Inc. (VERO)

Venus Concept Inc. is expanding the assembly of therapeutic systems in the Dominican Republic and Israel to optimize global logistics. Revenues are driven by the sale and servicing of laser rejuvenation and body contouring equipment. The company's debt-to-book capitalization ratio reflects borrowing dynamics, where the current status is 0.00. However, high borrowing costs and declining demand create significant financial risks.

Venus Concept Inc. - VERO Debts to Book Capitalization (period 07/04/2022 - 02/21/2026)

Summary analytical data breakdowns for Venus Concept Inc (VERO)

- price and consensus price forecast:
Stock Price Venus Concept Inc.|VERO - Average Forecast Price
- market capitalization data:
Market Value Venus Concept Corporation|VERO - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Venus Concept|VERO - Book Capitalization|Market Value to Book Value Ratio venusconcept.com|VERO - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Venus Concept Inc.|VERO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Venus Concept Corp|VERO - Company Aggregate Debts|Debt to Book Value Venus Concept Corporation|VERO - Amount of Long-Term Liabilities|Company Short-Term Debts Venus Concept
Analysis of all company metrics:VERO Venus Concept Inc.
Flagship merchandise of Venus Concept Corporation

The analyst assesses the creditworthiness of Venus Concept Inc. (VERO) through the lens of its debt load. Liability restructuring and low capacity utilization make financial stability a critical factor. The company's debt relative to its book capitalization compares total borrowings with equity. An increase in this indicator signals a risk of excessive leverage. It is essential for the investor to find a balance between security and capital efficiency.

Competitors of Venus Concept Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio